NNNN vs BFLY vs QDEL Stock Comparison

Anbio Biotechnology, Butterfly Network and QuidelOrtho Prices as of Nov 5, 2026 Peers: Industry group
1 more company in this comparison (NEOG) Create a free account to keep reading and compare up to 10 companies.
NNNN Anbio Biotechnology
$3.63 -25.9% 1M -83.5% 1Y
Market cap
$522.33M
P/E
24.8x
Revenue (TTM)
—
Div. yield
–
Diagnostic Equipment Healthcare
BFLY Butterfly Network, Inc.
$6.05 -30.5% 1M +141.0% 1Y
Market cap
$1.49B
P/E
–
Revenue (TTM)
$123.25M
Div. yield
–
Diagnostic Equipment Healthcare
5 wins
QDEL QuidelOrtho Corp
$12.84 +2.1% 1M -53.1% 1Y
Market cap
$880.82M
P/E
–
Revenue (TTM)
-$219.40M
Div. yield
–
Diagnostic Equipment Healthcare
1 win

Head to Head

6 decided of 12

Butterfly Network leads on 5 of the 12 questions below (Butterfly Network 5, QuidelOrtho 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionNNNNBFLYQDELLeader
Larger companyMarket capitalisation $522.33M $1.49B $880.82M BFLY
Cheaper on earningsLower P/E, profitable companies only 24.8x -29.5x -2.4x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS — — 17.1x –
Faster revenue growthRevenue growth, trailing twelve months — +39.4% -32.3% BFLY
More profitableNet margin, trailing twelve months — -43.6% — –
Better return on capitalReturn on invested capital — — — –
Less leveragedLower net debt / EBITDA — — — –
Higher dividend yieldTrailing dividend yield — — — –
Better 1-year returnPrice return, last 12 months -83.5% +141.0% -53.1% BFLY
Better 5-year returnAnnualised price return, 5 years — -10.3%/yr -36.2%/yr BFLY
Less volatileAnnualised volatility, 1 year 121.3% 112.8% 93.8% QDEL
Higher overall scoreMean of the five percentile scores vs peers — 49/100 28/100 BFLY

Percentile Scorecard

NNNNBFLYQDEL

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisNNNNBFLYQDEL
Valuation 18 #188 of 229 29 #164 of 229 58 #98 of 229
Growth – 90 #24 of 221 10 #199 of 221
Profitability – 38 #131 of 210 –
Financial Health 100 #1 of 240 57 #103 of 240 10 #217 of 240
Shareholder Returns – 34 #97 of 147 36 #94 of 147
Overall – 49 28
  • NNNN ranked among 247 companies in Medical Devices and Diagnostics
  • BFLY ranked among 247 companies in Medical Devices and Diagnostics
  • QDEL ranked among 247 companies in Medical Devices and Diagnostics

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodNNNNBFLYQDELSPY
1 month -25.9%-30.5%+2.1% -5.9%
3 months -63.9%-27.1%-21.3% -4.6%
6 months -86.0%+42.7%+19.2% +0.2%
Year to date -87.9%+59.2%-55.0% +7.5%
1 year -83.5%+141.0%-53.1% +8.2%
3 years —+476.2%-79.6% +68.3%
3 years, per year —+79.3%-41.1% +19.0%
5 years —-42.0%-89.4% +56.5%
5 years, per year —-10.3%-36.2% +9.4%
10 years ——-31.6% +251.5%
10 years, per year ——-3.7% +13.4%

Risk

MeasureNNNNBFLYQDELSPY
Volatility, 1Y 121.3%112.8%93.8% 13.6%
Downside volatility, 1Y 126.0%94.6%101.9% 14.2%
Beta vs S&P 500, 1Y 0.383.002.55 1.00
Return / volatility, 1Y -0.691.25-0.57 0.60
Max drawdown, 5Y -94.0%-93.1%-94.3% -25.4%
From 52-week high -91.2%-39.1%-63.7% -5.9%
52-week high $41.11$9.94$35.38 $779.14
52-week low $3.13$1.97$9.96 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleNNNNBFLYQDEL
P/E now vs peer median 24.8xmedian 26.9x -29.5xmedian 26.9x -2.4xmedian 26.9x
P/S now vs peer median 60.4xmedian 2.9x 12.1xmedian 2.9x -4.0xmedian 2.9x
EV/EBITDA now vs peer median —median 17.5x -26.8xmedian 17.5x —median 17.5x
P/FCF now vs peer median -77.5xmedian 26.4x -54.0xmedian 26.4x -7.5xmedian 26.4x
P/B now vs peer median 17.3xmedian 2.3x 8.1xmedian 2.3x 0.5xmedian 2.3x
PEG now vs peer median —median 0.88 -0.99median 0.88 0.03median 0.88

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsNNNNBFLYQDEL
Revenue – $123.25M -$219.40M
Gross profit – $86.60M –
Operating income – -$57.83M –
Net income – -$53.69M -$369.20M
Free cash flow – -$27.55M -$117.10M
R&D – $39.57M –
EPS (diluted) – $-0.20 $-5.37
Cash & equivalents $7.77M $122.30M $166.40M
Total debt – – $2.94B
Shares (diluted) 43.67M 262.10M 68.70M
Enterprise value $475.55M $952.33M $280.82M

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricNNNNBFLYQDEL
P/E 24.8x -29.5x -2.4x
P/FCF -77.5x -54.0x -7.5x
P/Operating cash flow – -63.6x 111.5x
P/S 60.4x 12.1x -4.0x
P/B 17.3x 8.1x 0.5x
P/Tangible book 17.3x 8.4x -1.1x
EV/EBITDA – -26.8x –
EV/EBIT – -23.6x –
EV/Revenue – 11.1x -16.6x
EV/FCF – -49.6x -31.2x
EV/Operating cash flow – -58.4x 462.2x
PEG (3Y EPS CAGR) – -0.99 0.03

Growth

14 metrics
MetricNNNNBFLYQDEL
Revenue growth (1Y) – 39.4% -32.3%
Revenue CAGR (3Y) – 21.7% -27.0%
Gross profit growth (1Y) – 126.4% –
Gross profit CAGR (3Y) – 30.5% –
Operating income growth (1Y) – 33.5% –
Operating income CAGR (3Y) – 26.9% –
Net income growth (1Y) – 32.8% 68.7%
Net income CAGR (3Y) – 24.2% -72.2%
EPS growth (1Y) – 35.4% 69.0%
EPS CAGR (3Y) – 30.0% -71.3%
Operating cash flow growth (1Y) – 5.8% -78.6%
Operating cash flow CAGR (3Y) – 41.1% -76.4%
Free cash flow growth (1Y) – -0.1% 23.9%
Free cash flow CAGR (3Y) – 38.8% -30.2%

Profitability

14 metrics
MetricNNNNBFLYQDEL
Gross margin – 70.3% –
EBITDA margin – -41.4% –
Operating margin – -46.9% –
Pretax margin – -43.5% –
Net margin – -43.6% –
FCF margin – -22.4% –
Operating cash flow margin – -19.0% -3.6%
Return on equity – -28.7% –
Return on assets – -18.8% –
Return on invested capital – – –
Return on capital employed – -26.6% –
Asset turnover – 0.4x 0.0x
Cash conversion (OCF / net income) – 0.4x 0.0x
Stock comp / revenue – 20.8% -20.7%

Financial Health

11 metrics
MetricNNNNBFLYQDEL
Debt / assets – – 50.8%
Debt / equity – – 1.6x
Net debt / EBITDA – – –
Debt / FCF – – -25.1x
Liabilities / assets 0.3% 36.0% 69.0%
Equity / assets 99.7% 64.0% 31.0%
Interest coverage – -46.8x –
Current ratio 344.3x 3.6x 1.4x
Quick ratio 177.1x 2.3x 0.5x
Cash ratio 135.5x 1.8x 0.2x
Altman Z-score – 4.66 –

Shareholder Returns

7 metrics
MetricNNNNBFLYQDEL
Dividend yield – – –
Net buyback yield – -0.6% -0.5%
Shareholder yield – -0.6% -0.5%
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusNNNNBFLYQDEL
Forward P/E – – 17.1xFY2026
EPS, next fiscal year – $-0.06FY2026 $0.75FY2026
EPS growth, next FY – – -64.6%FY2026
EPS growth, the year after – – +101.3%
Revenue, next fiscal year – $117.62MFY2026 $2.67BFY2026
Revenue growth, next FY – +20.5%FY2026 -2.0%FY2026
Revenue growth, the year after – +22.7% +0.2%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersNNNNBFLYQDEL
Held by institutions 0.0% 58.4% 100.0%
Institutions holding 12 248 243
Change in shares held, QoQ +39.8% +13.9% +2.9%
Institutions buying 8 144 143
Institutions selling 3 59 65
Buyers to sellers 2.67 2.44 2.20

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

NNNNBFLYQDEL
NNNN 1.00 0.10 -0.01
BFLY 0.10 1.00 0.23
QDEL -0.01 0.23 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, NNNN, BFLY and QDEL?

Butterfly Network (BFLY) is the largest by market capitalisation: Anbio Biotechnology (NNNN) $522.33M, Butterfly Network (BFLY) $1.49B, QuidelOrtho (QDEL) $880.82M.

Which company is growing faster?

Butterfly Network (BFLY) grew revenue fastest over the trailing twelve months: Butterfly Network (BFLY) +39.4%, QuidelOrtho (QDEL) -32.3%.

Which stock has performed better?

Over the past year Butterfly Network (BFLY) returned the most: Anbio Biotechnology (NNNN) -83.5%, Butterfly Network (BFLY) +141.0%, QuidelOrtho (QDEL) -53.1%. Over five years, Butterfly Network (BFLY) compounded fastest (Butterfly Network (BFLY) -10.3%/yr, QuidelOrtho (QDEL) -36.2%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, QuidelOrtho (QDEL) has been the steadiest (Anbio Biotechnology (NNNN) 121.3%, Butterfly Network (BFLY) 112.8%, QuidelOrtho (QDEL) 93.8%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, NNNN, BFLY and QDEL?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Butterfly Network (BFLY) leads on 5. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.